Cristina M. Rondinone

Author

Also Known As

C M RONDINONE, C M Rondinone, C. M. Rondinone, C.M. Rondinone, CRISTINA M. RONDINONE, CRISTINA RONDINONE, Cristina M Rondinone, Cristina M. Rondinone, Cristina Rondinone, E. Emmanouilidou

100

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Instituto de Investigaciones Biomédicas Sols-Morreale Universidad Autónoma de Madrid Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas Instituto de Salud Carlos III

About

Cristina M. Rondinone is an author at Abbott Fund specializing in medicine, cell signaling, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	39	3.4K
2	Health Sciences	19	23	1.4K
3	Cell Biology	18	20	1.7K
4	Biochemistry	17	19	1.5K
5	Natural Sciences	9	9	1K

Cristina M. Rondinone

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Perilipin is located on the surface layer of intracellular lipid droplets in adipocytes. E. Joan Blanchette‐Mackie, Nancy K. Dwyer, T Barber, Journal of Lipid Research	1995	471
PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice Bradley A. Zinker, Cristina M. Rondinone, James M. Trevillyan, Proceedings of the National Academy of Sciences	2002	412
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor Xuecai Ge, Hong Yang, Maria A. Bednarek, Cell Metabolism Molecular PhysiologySignal TransductionG Protein-coupled ReceptorMedicinePhysiology	2017	348
Serine/Threonine Phosphorylation of IRS-1 Triggers Its Degradation Terry M. Pederson, Deborah Kramer, Cristina M. Rondinone Diabetes Molecular BiologyInsulin SignalingReceptor Tyrosine KinaseIrs-1 TriggersMobility Shift	2001	298
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study Phil Ambery, Victoria E R Parker, Michael Stümvoll, The Lancet ObesityMetabolic SyndromeMedicineDiabetesType 2	2018	295
Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus Cristina M. Rondinone, Ling-Mei Wang, Peter Lönnroth, Proceedings of the National Academy of Sciences	1997	294
Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis Michelle L. Boland, Rhianna C. Laker, KARLY M. MATHER, Nature Metabolism InflammationMetabolic SyndromeFibrosisGcgr Dual-agonist CotadutideHepatology	2020	241
Robust anti‐obesity and metabolic effects of a dual <scp>GLP</scp> ‐1/glucagon receptor peptide agonist in rodents and non‐human primates Susan Henderson, Anish Konkar, David C. Hornigold, Diabetes Obesity and Metabolism	2016	233
Enhanced Basal Activation of Mitogen-Activated Protein Kinases in Adipocytes From Type 2 Diabetes C. J. Carlson, Sandra Koterski, Richard J. Sciotti, Diabetes Mitogen-activated Protein KinasesInsulin SignalingMetabolic SyndromeReceptor Tyrosine KinaseCell Signaling	2003	224
BMP4 and BMP Antagonists Regulate Human White and Beige Adipogenesis Birgit Gustafson, Ann Hammarstedt, Shahram Hedjazifar, Diabetes	2015	216

Page 1